scispace - formally typeset
M

Manel Sabaté

Researcher at University of Barcelona

Publications -  607
Citations -  26779

Manel Sabaté is an academic researcher from University of Barcelona. The author has contributed to research in topics: Stent & Myocardial infarction. The author has an hindex of 63, co-authored 549 publications receiving 23775 citations. Previous affiliations of Manel Sabaté include Complutense University of Madrid & Erasmus University Rotterdam.

Papers
More filters
Journal ArticleDOI

State-of-the-art and future perspective of percutaneous interventions for the management of STEMI

TL;DR: How primary percutaneous coronary intervention can be optimized with respect to stent selection and revascularization strategy to reduce myocardial damage and improve clinical outcomes is discussed.
Journal ArticleDOI

Paravalvular Leak Correction: Searching for a Balance Between Surgical and Percutaneous Techniques.

TL;DR: 1-Year follow-up outcomes Hospital admission, d 16.7 13.7 10.7 Procedural outcomes Procedural success 17 (94.4%) Residual leak (echocardiography) None or mild 16 (94%) Moderate 0 (0%) Severe 1 (6%) Complete PVL sealing 16 ( 94%) Procedural major adverse events 4 (16.6%) Death 2 (11.7%) Stroke 1 (5.5%)
Journal Article

Bioresorbable vascular scaffolds in clinical practice: state-of-the-art.

TL;DR: The main aim of this review is to carry out a systematic analysis and to evaluate long-term efficacy and safety of the Absorb BVS™.
Journal ArticleDOI

Coronary endothelial and microvascular function distal to polymer-free and endothelial cell-capturing drug-eluting stents. The randomized FUNCOMBO trial.

TL;DR: In this paper, the authors compared the endothelial function of the infarct-related artery (IRA) treated with bioactive circulating endothelial progenitor cell-capturing sirolimus-eluting stents (COMBO) vs polymer-free biolimus-ELuting stent (BioFreedom) at 6 months.
Journal Article

Diabetes mellitus and percutaneous coronary revascularization.

TL;DR: The main percutaneous techniques and their results in the diabetic population, from the early days of balloon angioplasty to the recently advent of drug eluting stents are reviewed.